AGP Executive Report
Last update: 12 hours agoPublic Health & Safety: Federal regulators issued a nationwide Class II recall for Levothyroxine after stability testing found certain lots were subpotent, raising the risk that patients may not get the correct thyroid dose. Medication Safety: Another Class II recall was reported for nearly 1 million bottles of heart and kidney drugs (including Corlanor and Sensipar) tied to foreign material concerns on tablet surfaces. Food Safety: Health officials flagged a “triple threat” of recalls and warnings spanning fresh herbs, lettuce, and shell eggs, with pathogens that can’t be fully washed away. Coastal Health: A new report highlights sargassum as a growing Caribbean and Atlantic problem, with decomposing seaweed linked to public health concerns as well as harbor and marine impacts. Local Health & Wellness Infrastructure: After Irma, the U.S. Virgin Islands is moving toward a virtual power plant by linking home solar and batteries to help stabilize the grid—supporting everyday needs like refrigeration and medical devices.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
